R. Cosintino

Statistics

Publications

Citations

860

H-Index

Active since

1987

Affiliations

Carlo Forlanini Hospital(Current)

University of Rome Tor Vergata

Ospedale San Filippo Neri

Imelda Hospital

Ospedale Vincenzo Cervello

R. Cosintino is an author at Carlo Forlanini Hospital specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and gastrointestinal inflammation.

ORCID

Publications per year

1987–2024

Publications

Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD)

Marco Daperno, Michele Comberlato, Fabrizio Bossa et al. · Digestive and Liver Disease · 2014 · 118 citations

Medicine, Clinical Sciences, Pathology +16

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Anti-tumour necrosis factor alpha (Infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients

Anna Kohn, Cosimo Prantera, A. Pera et al. · Digestive and Liver Disease · 2002 · 87 citations

Life Sciences, Immunology, Internal Medicine +14

1–5 of 13